UnknownNCT00313495
Cooperative Huntington's Observational Research Trial
Studying Huntington disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- HP Therapeutics Foundation
- Principal Investigator
- Ira Shoulson, MDUniversity of Rochester/Huntington Study Group
- Enrollment
- 5000 enrolled
- Eligibility
- All sexes
- Timeline
- 2006 – 2020
Study locations (30)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- UCLA School of Medicine, Los Angeles, California, United States
- University of California, Davis, Sacramento, California, United States
- University of California, San Diego, San Diego, California, United States
- University of California, San Francisco, San Francisco, California, United States
- Colorado Neurological Institute, Littleton, Colorado, United States
- University of Connecticut, Hartford, Connecticut, United States
- Institutue for Neurodegenerative Disorders, New Haven, Connecticut, United States
- University of Miami School of Medicine, Miami, Florida, United States
- University of South Florida, Tampa, Florida, United States
- Emory University, Atlanta, Georgia, United States
- Medical College of Georgia, Augusta, Georgia, United States
- Rush University Medical Center, Chicago, Illinois, United States
- University of Chicago, Chicago, Illinois, United States
- Indiana University School of Medicine, Indianapolis, Indiana, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Huntington Study Group
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00313495 on ClinicalTrials.govOther trials for Huntington disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07513844Optimizing Parameters of Low-Intensity Focused Ultrasound for Pallidal Modulation in Huntington's DiseaseFirst Affiliated Hospital of Fujian Medical University
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07537075An Extension of SKY-0515 in Participants With Huntington's DiseaseSkyhawk Therapeutics, Inc.
- RECRUITINGPHASE3NCT07326709A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's DiseaseNovartis Pharmaceuticals
- RECRUITINGPHASE1, PHASE2NCT07451613Safety and Tolerability Study of Human Neural Stem Cells for Huntington's DiseaseLeslie Thompson
- RECRUITINGEARLY PHASE1NCT06634628iMagemHTT-009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009CHDI Foundation, Inc.
- RECRUITINGPHASE2, PHASE3NCT07378644Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's DiseaseSkyhawk Therapeutics, Inc.
- RECRUITINGNCT07253038Evaluation of Three Tests to Assess Social Cognition in Huntington DiseaseRegion Skane
- RECRUITINGNANCT07213648Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)University of Virginia